Ann: Final Report delivered under Option Agreement, page-417

What they really need is for someone else to see ' Value ' in Monepantel should the ' Deal ' with Elanco perhaps fall over . An option or a ' Carry Trade ' if you like in the event Elanco do not exercise the options , and the ' New Comer ' gets leverage to the whole ' Box and Dice ' ......ie Human and Animal. So I guess what we ought to be looking for without necessarily Managements endorsement through an announcement is a ' Key ' stakeholder which by definition of their entry onto the register ' underwrite ' the potential value in Monepantel .

Think of it as sort of ' Branch Stacking ' or leveraging the outcome in your favor or someone's favor by taking a bit of insurance out if Elanco doesn't step up ..... And that is what I am thinking is going to happen . Especially when they release even a hint of success surrounding the Lung Tissue and the Remdesivir comparison's .......